Skip to main content
Year archive

Egetis Therapeutics — 2021 filings

All 33 regulatory filings released by Egetis Therapeutics (EGTX) in 2021, sourced directly from the official regulator.

33 Filings
2021 Period
2021 filings (33)
Filing Released Lang
Egetis planerar att lämna in ansökan om marknadsgodkännande för Emcitate® till den europeiska läkemedelsmyndigheten baserat på befintliga kliniska data
Regulatory Filings
2021-12-13 Swedish
Egetis intends to submit a marketing authorisation application for Emcitate® to the European Medicines Agency based on existing clinical data
Regulatory Filings
2021-12-13 English
Valberedning utsedd inför årsstämman 2022 i Egetis Therapeutics
Board/Management Information
2021-11-05 Swedish
Nomination Committee appointed for the 2022 Annual General Meeting in Egetis Therapeutics
Board/Management Information
2021-11-05 English
Interim / Quarterly Report 2021
Interim / Quarterly Report 9M 2021
2021-11-04 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report 9M 2021
2021-11-04 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-09-14 English
Interim / Quarterly Report 2021
Interim / Quarterly Report H2 2021
2021-08-19 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report H2 2021
2021-08-19 English
Chairman of the board of directors in Egetis Therapeutics acquires shares
Director's Dealing
2021-05-24 English
Styrelseordförande i Egetis Therapeutics förvärvar aktier
Director's Dealing
2021-05-24 Swedish
CEO and senior executives in Egetis Therapeutics acquire shares
Board/Management Information
2021-05-17 English
VD och ledande befattningshavare i Egetis Therapeutics förvärvar aktier
Director's Dealing
2021-05-17 Swedish
Bulletin from Egetis Therapeutics’ Annual General Meeting 2021
AGM Information
2021-04-29 English
Kommuniké från Egetis Therapeutics årsstämma 2021
AGM Information
2021-04-29 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Q1 2021
2021-04-22 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Q1 2021
2021-04-22 English
Egetis Therapeutics appoints Yilmaz Mahshid as new CFO
Board/Management Information
2021-04-19 English
Egetis Therapeutics utser Yilmaz Mahshid till ny CFO
Board/Management Information
2021-04-19 Swedish
Major Shareholding Notification 2021
Major Shareholding Notification
2021-04-15 English
Annual Report 2020
Annual Report FY 2020
2021-03-30 Swedish
Annual Report 2020
Annual Report FY 2020
2021-03-30 English
Mats Blom nominerad till ny styrelseledamot för Egetis Therapeutics
Board/Management Information
2021-03-26 Swedish
Mats Blom nominated as new board member at Egetis Therapeutics
Board/Management Information
2021-03-26 English
Dr Thomas Lönngren nomineras till ny styrelseordförande för Egetis Therapeutics
Board/Management Information
2021-03-26 Swedish
Dr Thomas Lönngren nominated as new Chairman of the Board at Egetis Therapeutics
Board/Management Information
2021-03-26 English
KALLELSE TILL ÅRSSTÄMMA I EGETIS THERAPEUTICS AB
Proxy Solicitation & Information Statement
2021-03-26 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Q4 2020
2021-02-17 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Q4 2020
2021-02-17 English
Egetis Therapeutics utser Dr Kristina Sjöblom Nygren till ny CMO
Board/Management Information
2021-02-15 Swedish
Egetis appoints Dr Kristina Sjöblom Nygren as new CMO
Board/Management Information
2021-02-15 English
Peder Walberg appointed as interim Chief Medical Officer
Board/Management Information
2021-01-20 English
Peder Walberg utsedd till interim Chief Medical Officer
Board/Management Information
2021-01-20 Swedish